Summit Therapeutics Inc. (SMMT) Capital expenditures 2017–2025
Summit Therapeutics Inc. (SMMT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$657,000FY2025 · since FY2017: $668,000 → $657,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $657,000 | +372.7% |
| FY2024 | $139,000 | +8.6% |
| FY2023 | $128,000 | -79.5% |
| FY2022 | $624,000 | +103.9% |
| FY2021 | $306,000 | -27.3% |
| FY2020 | $421,000 | — |
| FY2018 | $157,000 | -76.5% |
| FY2017 | $668,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice